1,418
Views
5
CrossRef citations to date
0
Altmetric
Articles

Protective effects of astaxanthin on diabetic cardiomyopathy in rats

Efectos protectores de la astaxantina en ratas que padecen miocardiopatía diabética

&
Pages 909-915 | Received 24 Apr 2018, Accepted 09 Jul 2018, Published online: 17 Oct 2018

References

  • Aoi, W., Naito, Y., Sakuma, K., Kuchide, M., Tokuda, H., Maoka, T., Yoshikawa, T. (2003). Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. Antioxidants & Redox Signaling, 5(1), 139–144.
  • Association, A. D. (2009). Diagnosis and classification of diabetes mellitus. Diabetes Care, 32(Suppl 1), S62–S67.
  • Brahma, M. K., Pepin, M. E., & Wende, A. R. (2017). My sweetheart is broken: Role of glucose in diabetic cardiomyopathy. Diabetes & Metabolism Journal, 41(1), 1–9.
  • Chen, F. P., Li, B. G., & Wu, X. M. (2009). Significance of detection of GLU, HbA1c and blood lipid in type 2 diabetes patients. China Tropical Medicine, 9(6), 1059–1060. In Chinese
  • Djordjevic, A., Spasic, S., Jovanovic-Galovic, A., Djordjevic, R., & Grubor-Lajsic, G. (2004). Oxidative stress in diabetic pregnancy: SOD, CAT and GSH-Px activity and lipid peroxidation products. Journal of Maternal-Fetal & Neonatal Medicine, 16(6), 367–372.
  • Ge, M., Ma, S., Tao, L., & Guan, S. (2009). The effect of gypenosides on cardiac function and expression of cytoskeletal genes of myocardium in diabetic cardiomyopathy rats. American Journal of Chinese Medicine, 37(6), 1059–1068.
  • Guo, S. X., Zhou, H. L., Huang, C. L., You, C. G., Fang, Q., Wu, P., … Han, C. M. (2015). Astaxanthin attenuates early acute kidney injury following severe burns in rats by ameliorating oxidative stress and mitochondrial-related apoptosis. Marine Drugs, 13(4), 2105–2123.
  • Guo, Y., Shi, D. Z., Yin, H. J., & Chen, K. J. (2007). Effects of Tribuli saponins on ventricular remodeling after myocardial infarction in hyperlipidemic rats. American Journal of Chinese Medicine, 35(2), 309–316.
  • Harrison, R., & Bray, R. C. (1997). Xanthine oxidase: Enzymology and pathophysiology. Biochemical Society Transactions, 25(3), 749–750.
  • Hayat, S. A., Patel, B., Khattar, R. S., & Malik, R. A. (2004). Diabetic cardiomyopathy: Mechanisms, diagnosis and treatment. Clinical Science, 107(6), 539–557.
  • Higashi, Y., & Yoshizumi, M. (2004). Oxidative stress, reactive oxygen species. Nihon Rinsho, 62(1), 49–55. Article in Japanese
  • Higuera-Ciapara, I., Félix-Valenzuela, L., & Goycoolea, F. M. (2006). Astaxanthin: A review of its chemistry and applications. Critical Reviews in Food Science and Nutrition, 46(2), 185–196.
  • Hussein, G., Nakagawa, T., Goto, H., Shimada, Y., Matsumoto, K., Sankawa, U., & Watanabe, H. (2007). Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp. Life Sciences, 80(6), 522–529.
  • Kim, Y. H., Koh, H. K., & Kim, D. S. (2010). Down-regulation of IL-6 production by astaxanthin via ERK-, MSK-, and NF-κB-mediated signals in activated microglia. International Immunopharmacology, 10(12), 1560–1572.
  • Lakshmanan, A. P., Harima, M., Sukumaran, V., Soetikno, V., Thandavarayan, R. A., Suzuki, K., … Watanabe, K. (2012). Modulation of AT-1R/AMPK-MAPK cascade plays crucial role for the pathogenesis of diabetic cardiomyopathy in transgenic type 2 diabetic (Spontaneous Diabetic Torii) rats. Biochemical Pharmacology, 83(5), 653–660.
  • Li, J., Xia, Y., Liu, T., Wang, J., Dai, W., Wang, F., … Guo, C. (2015). Protective effects of astaxanthin on ConA-induced autoimmune hepatitis by the JNK/p-JNK pathway-mediated inhibition of autophagy and apoptosis. PLoS One, 10(3), e0120440.
  • Luo, B., Li, B., Wang, W., Liu, X., Liu, X., Xia, Y., … An, F. (2014). Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Cardiovascular Drugs and Therapy, 28(1), 33–43.
  • Martinez, P. F., Bonomo, C., Guizoni, D. M., Junior, S. A., Damatto, R. L., Cezar, M. D., … Okoshi, M. P. (2015). Influence of N- acetylcysteine on oxidative stress in slow-twitch soleus muscle of heart failure rats. Cellular Physiology & Biochemistry, 35(1), 148–159.
  • Mashhadi, N. S., Zakerkish, M., Mohammadiasl, J., Zarei, M., Mohammadshahi, M., & Haghighizadeh, M. H. (2018). Astaxanthin improves glucose metabolism and reduces blood pressure in patients with type 2 diabetes mellitus. Asia Pacific Journal of Clinical Nutrition, 27(2), 341–346.
  • Memon, A. A., Wahid, H., Rosnina, Y., Goh, Y. M., Ebrahimi, M., & Nadia, F. M. (2012). Effect of antioxidants on post thaw microscopic, oxidative stress parameter and fertility of Boer goat spermatozoa in Tris egg yolk glycerol extender. Animal Reproduction Science, 136(1–2), 55–60.
  • Murakami-Mori, K., Mori, S., Bonavida, B., & Nakamura, S. (1999). Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi’s sarcoma cells: A possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi’s sarcoma cells. Journal of Immunology, 162(6), 3672–3679.
  • Naito, Y., Uchiyama, K., Aoi, W., Hasegawa, G., Nakamura, N., Yoshida, N., … Yoshikawa, T. (2004). Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors, 20(1), 49–59.
  • Opara, E. C. (2002). Oxidative stress, micronutrients, diabetes mellitus and its complications. The Journal of the Royal Society for the Promotion of Health, 122(1), 28–34.
  • Pei, L. P., Bai, Y., Huang, H. Q., Li, Z. Y., Liu, W. Z., & Hui, B. D. (2012). Effect of astaxanthin on the lipid levels of hyperlipidemia rat. Chinese Journal of Gerontology, 32(18), 1936–3938. In Chinese
  • Pirinccioglu, A. G., Gökalp, D., Pirinccioglu, M., Kizil, G., & Kizil, M. (2010). Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia. Clinical Biochemistry, 43(15), 1220–1224.
  • Qiao, H., Zhang, X., Zhu, C., Dong, L., Wang, L., Zhang, X., … Cao, X. (2012). Luteolin downregulates TLR4, TLR5, NF-κB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia. Brain Research, 1448, 71–81.
  • Riad, A., Unger, D., Du, J., Westermann, D., Mohr, Z., Sobirey, M., … Tschöpe, C. (2007). Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus. European Journal of Pharmacology, 554(1), 40–45.
  • Ritchie, R. H., Zerenturk, E. J., Prakoso, D., & Calkin, A. C. (2017). Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy. Journal of Molecular Endocrinolgy, 58(4), R225–R240.
  • Rossen, J. D. (1996). Abnormal microvascular function in diabetes: Relationship to diabetic cardiomyopathy. Coronary Artery Disease, 7(2), 133–138.
  • Russell, N. E., Foley, M., Kinsley, B. T., Firth, R. G., Coffey, M., & McAuliffe, F. M. (2008). Effect of pregestational diabetes mellitus on fetal cardiac function and structure. American Journal of Obstetrics and Gynecology, 199(3), 312.e1-312.e7.
  • Seger, R., & Krebs, E. G. (1995). The MAPK signaling cascade. FASEB Journal, 9(9), 726–735.
  • Stannus, O., Jones, G., Cicuttini, F., Parameswaran, V., Quinn, S., Burgess, J., & Ding, C. (2010). Circulating levels of IL-6 and TNF-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis and Cartilage, 18(11), 1441–1447.
  • Sun, X., Chen, R. C., Yang, Z. H., Sun, G. B., Wang, M., Ma, X. J., … Sun, X. B. (2014). Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis. Food and Chemical Toxicology, 63, 221–232.
  • Uzgare, A. R., Kaplan, P. J., & Greenberg, N. M. (2003). Differential expression and/or activation of p38MAPK, Erkl/2, and Jnk during the initiation and progression of prostate cancer. Prostate 55: 128-139. Prostate, 55, (2), 128–139. doi:10.1002/pros.10212
  • Wagner, E. F., & Nebreda, A. R. (2009). Signal integration by JNK and p38 MAPK pathways in cancer development. Nature Reviews Cancer, 9(8), 459–537.
  • Wen, H. L., Liang, Z. S., Zhang, R., & Yang, K. (2013). Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy. Cardiovascular Diabetology, 12, 50.
  • Yan, T., Zhao, Y., Zhang, X., & Lin, X. (2016). Astaxanthin inhibits acetaldehyde-induced cytotoxicity in SH-SY5Y cells by modulating Akt/CREB and p38MAPK/ERK signaling pathways. Marine Drugs, 14(3), In Chinese 56–58.
  • Yang, Q., Zhang, Z., Zhu, X., Ruan, H., & Fu, Y. (2009). Therapeutic effect of astaxanthin on acetic acid-induced gastric ulcer in rats. Acta Pharmaceutica Sinica, 44(5), 558–560. In Chinese
  • Ying, C. J., Zhang, F., Zhou, X. Y., Hu, X. T., Chen, J., Wen, X. R., … Song, Y. J. (2015). Anti-inflammatory effect of astaxanthin on the sickness behavior induced by diabetes mellitus. Cellular & Molecular Neurobiology, 35(7), 1027–1037.
  • Zhou, X., Zhang, F., Hu, X., Chen, J., Wen, X., Sun, Y., … Song, Y. (2015). Inhibition of inflammation by astaxanthin alleviates cognition deficits in diabetic mice. Physiology & Behavior, 151, 412–420.